Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00684099

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece
View Trial Details
Completed

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

NCT00615758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
  • Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece
  • IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece
  • Sotiria" General Hospital, 2nd Dep of Pulmonary Diseases Athens, Greece
View Trial Details
Completed

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00370292

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milan, Italy
View Trial Details
Completed

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

NCT00712504

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Nashville, Tennessee, United States
View Trial Details
Completed

Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

NCT00441740

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • " General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece
View Trial Details
Completed

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

NCT00441922

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Department of Medical Oncology Alexandroupoli, Greece
  • 401 Military Hospital of Athens Athens, Greece
  • Air Forces Military Hospital of Athens Athens, Greece
  • IASO General Hospital of Athens, 1st Department of Medical Oncology Athens, Greece
View Trial Details

Related conditions